The International Foundation first conducted this survey in January 2024
Weight-loss drugs have been around for decades
Popular options like Ozempic, Wegovy, and Mounjaro have shown significant weight loss benefits
Emerging data shows benefits for osteoarthritis, kidney health, and sleep apnea
Phase 2 trials have reported substantial mean weight losses of up to 24.2% at 48 weeks in individuals with obesity, with high percentages of participants achieving clinically meaningful thresholds (e.g., 83-93% achieving 15% weight loss at higher doses)
It is our best-selling peptide protocol, and the nickname is earned: these two peptides work through complementary mechanisms that, together, support your body's ability to repair tissue, reduce inflammation, and recover faster from injury or overuse